Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES

Aksel Siva, Orhun Kantarci

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES'. Together they form a unique fingerprint.